Puratrophin 1 inhibitors are a class of chemical compounds that target the Puratrophin 1 protein, a molecular component involved in cellular signaling and regulatory pathways. Puratrophin 1, a member of a broader family of proteins with structural and functional significance, plays a role in various cellular processes. The inhibition of this protein by specific small molecules or macromolecular inhibitors leads to changes in cellular signaling cascades, potentially affecting the normal and aberrant regulation of physiological pathways. Puratrophin 1 inhibitors are often characterized by their ability to selectively bind to and modulate the activity of the Puratrophin 1 protein, either through direct binding to its active site or by inducing conformational changes that affect its function. Structurally, these inhibitors may possess diverse chemical backbones but share common features that confer specificity and high affinity for the Puratrophin 1 protein.
The structural diversity of Puratrophin 1 inhibitors allows them to interact with different domains or pockets within the protein, making them versatile in their mechanism of action. These inhibitors often exhibit various binding modes, including reversible or irreversible interactions, competitive or allosteric binding, and they can demonstrate varying levels of potency based on their chemical structures. In designing Puratrophin 1 inhibitors, chemical modifications can be made to enhance selectivity, stability, and binding efficiency. The physiochemical properties of these compounds, such as lipophilicity, polarity, and molecular size, influence their bioavailability and interactions with cellular targets. Furthermore, the specificity of Puratrophin 1 inhibitors can be fine-tuned through structure-activity relationship (SAR) studies, enabling the design of compounds with optimized inhibitory activity. These inhibitors are critical tools for studying the functional role of Puratrophin 1 in cellular signaling and for elucidating the protein's contributions to various biochemical pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Can impact Wnt signaling, which might intersect with pathways regulated by Puratrophin 1. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor known to modulate Wnt/β-catenin signaling, potentially affecting Puratrophin 1 related pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibitor of MEK, which can affect MAPK/ERK pathway, likely intersecting with Puratrophin 1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can influence autophagy and protein degradation pathways, potentially altering Puratrophin 1 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect Akt signaling, possibly intersecting with Puratrophin 1 regulatory mechanisms. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Specific inhibitor of V-ATPase that can disrupt lysosomal acidification and autophagy, affecting Puratrophin 1 function. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Hedgehog signaling pathway inhibitor that can modify cellular processes potentially regulated by Puratrophin 1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibitor of JNK, which may influence signaling pathways involving Puratrophin 1. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Inhibitor of BMP signaling that could intersect with Puratrophin 1-related pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Signaling molecule that regulates gene expression and may affect pathways involving Puratrophin 1. | ||||||